Non-invasive biomarkers of liver disease as prognostic indicators in patients with Fontan circulation

Atrial Fibrillation

Impact of steatotic liver diseases on diabetes mellitus risk in patients with atrial fibrillation: a nationwide population study

Cardiovasc Diabetol

Ryu H, Lee SR, Choi EK, Go YH, Lee KY, Choi J, Han S, Kim JH, Ahn HJ, Kwon S, Kim BS, Han KD, Oh S, Lip GYH

doi: 10.1186/s12933-025-02795-5

Cardiovascular Risk and Diseases

Expanded Field OCTA Biomarkers Associated with Future Cardiovascular Disease and Mortality in Patients with Diabetic Retinopathy

Retina

Lu ES, Cui Y, Phu KK, Ding X, Nodecker KN, Le R, Zhu Y, Garg I, Baldwin G, Rodriguez J, Finn MJ, Razavi P, Laíns I, Wu DM, Husain D, Kim LA, Patel NA, Vavvas DG, Miller JB

doi: 10.1097/IAE.0000000000004695

Heart Failure

Prognostic impact of rheumatic diseases in patients with heart failure with mildly reduced ejection fraction

Clin Res Cardiol

Goertz M, Schupp T, Dudda J, Weidner K, Lau F, Schmitt A, Abel N, Abumayyaleh M, Steffen HJ, Langer HF, Duerschmied D, Akin I, Behnes M

doi: 10.1007/s00392-025-02740-2

Further Publications

Unplanned Hospitalization Due to All-Cause Morbidity and Its Real-World Management Practices in Patients With Fontan Circulation

J Am Heart Assoc

Ohuchi H, Takei K, Muneuchi J, Kasahara S, Ishikawa Y, Muraji S, Tsukada M, Nii M, Ono S, Takamuro M, Saiki H, Fujino M, Kuraishi K, Lin L, Miyazaki A, Sakamoto I, Masutani S, Hayabuchi Y, Ohashi H, Yasuda K, Seki M, Mori A, Nakai M

doi: 10.1161/JAHA.125.044374

Atrial FibrillationHeart Failure

Associations between biomarkers and p-wave indices in relation to atrial fibrillation development in heart failure patients

Heart Rhythm

Nezami Z, Jujic A, Ohlsson M, Magnusson M, Isholth HH, Platonov P

doi: 10.1016/j.hrthm.2025.11.015

Myocardial Infarction

Anatomical, physiological and inflammatory characterization of non-culprit vessels in patients undergoing primary PCI for ST-elevation myocardial infarction in the presence of multivessel disease: Rationale and design of the PICNIC study

Am Heart J

Mahmoudi M, Nicholas Z, Jabbour RJ, Shambrook J, Abbas A, Browne T, Hinton J, Antoniades C, Mamas M, Leipsic J, Rogers C, Koo BK, Al-Lamee R, Kontopantelis E, Curzen N

doi: 10.1016/j.ahj.2025.107298

Heart Failure

Aggregate index of systemic inflammation as a novel prognostic biomarker in Chinese patients with acute decompensated heart failure: a population-based real-world study

Front Endocrinol (Lausanne)

Hu L, Deng Y, Liu C, Kuang Y, Huang X, Zhang J, Huang W, Jian Y, Xie G, Zou Y, Zhang S

doi: 10.3389/fendo.2025.1627821

Cardiovascular Risk and Diseases

Cardiovascular risk assessment tools are insufficient for patients with metabolic dysfunction associated steatotic liver disease

Am J Gastroenterol

Barritt AS 4th, Tapper EB, Newsome PN, Gazis D, Morris H, Mospan AR, Perez AD, Kim Y, Neuschwander-Tetri BA, Loomba R, Sanyal A, TARGET-NASH Investigators

doi: 10.14309/ajg.0000000000003595

Heart, Artery and Coronary Diseases

Prognostic Value of Plaque Volume in Patients With First Diagnosis of Coronary Artery Disease: A Substudy of the PROMISE Randomized Clinical Trial

JAMA Cardiol

Karády J, Mayrhofer T, Brendel JM, Kolossváry M, Langenbach M, Langenbach I, Baliyan V, Sturniolo AK, Pagidipati N, Lu MT, Ferencik M, Shah S, Douglas PS, Foldyna B

doi: 10.1001/jamacardio.2025.5520

Related content